Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | 712 | 1,119 | 92 | 188 | 557 |
| Gross Profit | 712 | 1,119 | 92 | 188 | 557 |
| Operating Expenses | 8,853 | 7,340 | 1,954 | 7,805 | 16,452 |
| Operating Income | -8,141 | -6,220 | -1,862 | -7,617 | -15,895 |
| Interest Expense | 0 | 0 | 0 | 577 | 0 |
| Other Income | -431 | -1,338 | -3,057 | 0 | -781 |
| Pre-tax Income | -8,572 | -7,559 | -4,919 | -8,194 | -16,675 |
| Income Tax | -200 | -213 | -237 | -150 | N/A |
| Net Income Continuous | -8,372 | -7,345 | -4,682 | -8,044 | -16,675 |
| Minority Interests | N/A | N/A | N/A | N/A | -128 |
| Net Income | $-8,372 | $-7,345 | $-4,682 | $-8,044 | $-16,548 |
| EPS Basic Total Ops | -57.31 | -63.87 | -48.38 | -85.95 | -193.44 |
| EPS Basic Continuous Ops | -57.30 | -63.87 | -48.39 | -85.94 | -195.07 |
| EPS Diluted Total Ops | -57.31 | -63.87 | -48.38 | -85.95 | -193.44 |
| EPS Diluted Continuous Ops | -57.30 | -63.87 | -48.39 | -85.94 | -195.07 |
| EPS Diluted Before Non-Recurring Items | -65.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-7,413 | $-5,445 | $-662 | $-6,547 | $-15,013 |